LOS ANGELES--(BUSINESS WIRE)--Pelage Pharmaceuticals, a clinical-stage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback